Authors : Dr. Beulah Milton; Abdul Mohammed Basha; Christo Sebastian; Dr. Ravi Kumar

Volume/Issue : Volume 9 - 2024, Issue 9 - September

Google Scholar : https://tinyurl.com/5d96nt2k

Scribd : https://tinyurl.com/yc8e6va8

DOI : https://doi.org/10.38124/ijisrt/IJISRT24SEP1417

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : The most common invasive procedure that patients admitted to hospital wards likely undergo is intravenous (IV) access. Medications through IV fluid injection is administered to up to 80% of hospital patients. Certain medications, such as phenytoin, vancomycin, ampicillin/sulbactam combinations, steroids, and cefotaxime, might result in abrupt responses when intravenous fluids are administered. antibiotics such as mitomycin, daunorubicin, dactinomycin, and doxorubicin. Antineoplastic drugs such as methotrexate, cyclophosphamide, etoposide, vinorelbine, carboplatin, oxaliplatin, paclitaxel, and epirubicin. Dopamine, noradrenaline, amiodarone, adrenaline, and pituitrin are examples of inotropic substances. Bevacizumab, Cisplatin, Heparin, Glucocorticoids, Tamoxifen, Testosterone, and Antidepressants. When administering IV medication, Clinical Pharmacist are crucial in identifying and reporting drugs that cause acute responses. Clinical Pharmacist can be involved because they can be crucial in ensuring safe pharmaceutical use in hospitals.

Keywords : Medications, Acute Reactions, Intravenous Fluids.

References :

1. Gelena HJ. Complications occurring from diagnostic venepuncture. J Fam Pract. 1992; 34:582–4.
2. World Health Organization. WHO guidelines on drawing blood: Best practices in phlebotomy. 2010.
3. Mermel LA. Short-term peripheral venous catheter-related bloodstream infections: a systematic review. Clin Infect Dis. 2017;65(10):1757–1762. doi:10.1093/cid/cix562.
4. Dychter SS, Gold DA, Carson D, Haller H. Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012;35(2):84–91. doi:10.1097/NAN.0b013e 31824237ce.
5. Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice. J Infus Nurs. 2021;44(1S suppl 1): S1–S224. doi:10.1097/NAN. 0000000000000396.
6. Lewis SM, Heitkemper MM, Dirksen SR. Medical surgical nursing. 6th ed. St.Louis: Westline Industrial Drive: 2000
7. Lundgren A, Jorfeldt L and EK A. The core and handling of peripheral IV cannulas on 60 surgery and internal medicine patients, an observation study. Journal of advanced Nursing,1983; July, 18, 963 971.
8. 8.Black JM; Hawks JH. Medical surgical nursing: Clinical management for positive outcomes. 8th ed. St. Louis: Westline Industrial Drive: 2009
9. Easterlow D, Hoddinott P, Harrisons, “Implementing & Standardising the use of Peripheral vascular access devices” J Clin Nurs 2010 Mar: 19 (5-6): 721-7.
10. 10.Tagalakis V, Kahn SR,Libman M ,The epidemiology of peripheral vein infusion thrombophlebitis, a critical review ,2004;Aug1;113 (2):146 151 .